Publication | Closed Access
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and <sup>90</sup>yttrium‐DOTA‐peptide‐ChL6
68
Citations
34
References
2001
Year
In the PC3-tumor nude mouse model, addition of paclitaxel or docetaxel to 90Y-DOTA-peptide-ChL6, in doses clinically achievable in humans, provided therapeutic synergy without increased or excessive toxicity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1